|

What are the Benefits of MICRODOSING Psilocybin? | Interview with a Microdosing Expert

What are the benefits of Microdosing psilocybin? | Interview with a Microdosing Expert

In today’s episode, we sit down with microdosing expert Sena Maria of The Medicine of Being Human and MicrodosingForResilience.com.

In this interview, we learn about Sena’s microdosing business, which helps people begin microdosing psilocybin (note she does not provide any illegal substances, only coaches people on how to microdose) and the benefits that microdosing can bring.

For example, Sena gives us a fantastic Top 5 Benefits of Microdosing at some point in our chat.

Some of the questions that we covered were:
-What is microdosing and what are the benefits?
-How/ why did you start microdosing ?
-What is your microdosing regiment?
-What benefits have you personally seen from this?
-What do you wish people knew about psychedelics that they don’t currently?
-Can Microdosing magic mushrooms help with addiction?
-Can microdosing help treat depression or anxiety?

On top of discussing the how and why of microdosing psychedelics, Sena also discussed how these medicines have been known for generations in some aboriginal tribes, and how Western Medicine may still have a lot to learn.

Timestamps
00:00- Intro
1:32 – Sena Maria’s journey to microdosing: From Google to Psychedelics
4:15- Microdosing For Resilience
5:58- How to microdose psilocybin
8:20- Top 5 benefits of Microdosing
13:31- What is missed in the psychedelics conversation?
18:34- Sena’s Psychedelic Ceremony experiences
22:05 – How did you integrate what you learned in your psychedelic ceremony

#Microdosing #MicrodosingBenefits #Psychedelics

Similar Posts

  • This Week in Psychedelic Stocks [UPDATES ON MINDMED (MMED/MMEDF) CMPS, NUMI, FTPRF, ATAI & CYBN]

    In today’s episode of “This Week in Psychedelic Stocks”, we’ll see some News on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Atai Life Sciences, Numinus Wellness (NUMI), Cybin (CYBN) & Fieldtrip Health (FTPRF).

    I covered some breaking news on MindMed yesterday in our impromptu episode on the MindMed stock being added to the EFSE so that mindmed news is not in this episode.

    We will cover the latest developments in the field writ large.
    This means we will cover any stories that affect the all the companies in this field, as well as company specific developments.

    Timestamps:
    0:00 – Intro
    0:43 – Australian federal government funds psychedelic research to treat mental illnesses
    2:19 – Rhode Island wants to decriminalize all drugs
    3:54 – New York Bill to decriminalize psilocybin mushrooms
    6:34 – MindMed stock updates ( mmed, mmedf, mmq )
    8:17 – Compass Pathways stock news (cmps)
    8:49 – Atai Life Sciences news
    12:37 – Fieldtrip Health stock news ( ftprf, ftrp)
    15:04 – Numinus Wellness stock news ( NUMI, LKYSF)
    16:16 – Cybin stock news ( cybn, clxpf)
    18:18 General psychedelics discussion

    So this is it for This Week in Psychedelic Stocks fellow psychedelic investors!

    I hope you guys found some value in this and I’ll keep you posted for more changes!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #MindMed​​ ​#MindmedStock​​ #PsychedelicStocks

  • Top 5 PSYCHEDELIC STOCKS to buy in 2021 (MMEDF, NUMI, RVV, FTRP, CMPS🔥)

    We hope that YOU, the psychedelic investor, were able to gain some value from this! 🧠📈 Feel free to drop a comment! 💬 Also, you can support the channel by liking the video and checking out the links below.👇🏼 Appreciate you. 🙏🏼

    There’s a SHROOM BOOM on its way. Psychedelic companies are IPOing left and right and along with them are the top 5 psychedelic stocks to buy in 2020! On this list we got:

    Revive Therapeutics (RVV), Numinus (NUMI), Field Trip (FTRP), Compass Pathways (CMPS), and last but not least…MinDMed (MMEDF).

    Beat by: Prod. Riddiman
    Stream beats on:
    Spotify: https://spoti.fi/2u4ZS7R
    Apple Music: https://apple.co/2GIxb8j
    Music: www.bensound.com
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

  • MindMed Facing Competition From HAVN? Plus Financials and Phase 2 Trials (MNMD, CYBIN, HAVN, MYCO)

    Hey guys! In this week’s industry specific news, we’ll cover some interesting developments for MindMed, Mydecine, Cybin, HAVN, and a private company called WAKE. One of the biggest highlights is that HAVN might enter in direct competition with MindMed by penetrating the cluster headaches market. Stay tuned till the end the hear more on this specific news!

    Timestamps:

    0:00 – Intro
    1:00 – MindMed Begins a Mescaline Study
    4:35 – MindMed & The Chopra Foundation
    8:30 – Cybin Progresses Phase 2a psilocybin study
    11:56 – Mydecine announces Q1 Financials
    14:16 – Havn Life Sciences enters the Cluster Headaches Game
    16:30 – Wake Receives First-Ever Approval for Psilocybin for Anxiety & Depression

    Enjoy!
    Links:
    MindMed (MNMD/ MMED / MMQ)) Begins a Mescaline Study:
    https://mindmed.co/news/press-release/mindmed-announces-the-approval-of-mescaline-study/

    MindMed Partners Up with The Chopra foundation:
    https://mindmed.co/news/press-release/the-chopra-foundation-and-mindmed-enter-into-letter-of-intent-to-partner-on-the-future-of-psychedelic-medicines-mental-wellbeing/

    Cybin (CYBN) Progresses Phase IIa psilocybin film strip study:
    https://www.clinicaltrialsarena.com/news/cybin-phase-ii-psilocybin/

    Mydecine (MYCO / MYCOF) Q1 Financials:
    https://psilocybinalpha.com/news/mydecine-reports-first-quarter-2021-financial-results-and-provides-business-update

    Havn Life Sciences (HAVN/ HAVLF/ 5NP) Begins to Study Cluster Headaches
    https://havnlife.com/havn-life-enters-into-agreement-to-acquire-clinical-stage-ip-for-development-of-lsd-derived-api-for-cluster-headaches/

    Wake Receives First-Ever Approval for Psilocybin Microdose Study for Anxiety and Depression
    https://psychedelicspotlight.com/wake-psilocybin-microdose-study/

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @thepsychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    Video editing: @themyaholy
    https://benzinga.grsm.io/jameshallifa…

    https://benzinga.grsm.io/thepsychedel…

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #PsychedelicStocks #HAVN